Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03286452 · ClinicalTrials.gov registry record
The RESPOND Registry
A clinical trial of Venous Ulcer and Pressure Ulcer, sponsored by Organogenesis.
- Completed
- Registry status
- 310
- Enrollment target
- 15
- Study locations
NCT03286452 is a study of Venous Ulcer and Pressure Ulcer that has completed, run by Organogenesis. The registered enrollment target is 310 participants, above the 132-participant average among 11 other Venous Ulcer trials with a reported enrollment target (135% higher). The trial reports 15 study locations across 10 states.
The verdict
NCT03286452, a study of Venous Ulcer and Pressure Ulcer, has completed, sponsored by Organogenesis.
- COMPLETED
- Registry status
- 310 participants
- Enrollment target
- 15
- Study locations
Study Summary
The RESPOND Registry is an observational study to assess the impact of PuraPly™ AM on the management of wounds in real world clinical settings; no experimental intervention is involved.
Conditions Studied
Interventions
- DEVICE PuraPly™ Antimicrobial Wound Matrix
Study Locations (15)
Louisiana
- Institute for Advanced Wound Healing; Northshore Specialty Hospital - Covington
- Wound Care Associates, LLC. - Hammond
- Opelousas General Hospital Wound Center - Opelousas
Florida
- Jupiter Medical Center - Jupiter
- West Gables Rehab Hospital - Miami
New Jersey
- CentraState Medical Center - Freehold
- Robert Wood Johnson Hamilton - Hamilton
Pennsylvania
- Sacred Heart Hospital - Allentown
- Harrisburg Foot and Ankle Center, Inc. - Harrisburg
Arizona
- Advanced Wound Care Center at Yavapai Regional Medical Center - Prescott Valley
Missouri
- Saint Louis Foot and Ankle - St Louis
New York
- Southampton Hospital - Southampton
North Carolina
- Wayne Memorial Hospital - Goldsboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 310 participants |
| Start Date | 2017-02-21 |
| Est. Completion | 2019-01-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03286452
The ClinicalTrials.gov registry entry for NCT03286452 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 310 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 132-participant average among 11 other Venous Ulcer trials with a reported enrollment target (135% higher). The listed sponsor is Organogenesis, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Venous Ulcer appearing as the primary indexed condition, and to 1 intervention - of which PuraPly™ Antimicrobial Wound Matrix is the first listed.
NCT03286452 reports 15 study locations spanning 10 distinct geographic areas - top geographies include Louisiana, Florida, New Jersey.
Frequently Asked Questions
What is clinical trial NCT03286452 about?
NCT03286452 is a clinical study titled "The RESPOND Registry". The RESPOND Registry is an observational study to assess the impact of PuraPly™ AM on the management of wounds in real world clinical settings; no experimental intervention is involved.
What is the current status of trial NCT03286452?
This trial is currently completed. The enrollment target is 310 participants. The study started on 2017-02-21. Estimated completion is 2019-01-26.
What conditions does trial NCT03286452 study?
This clinical trial studies the following conditions: Venous Ulcer, Pressure Ulcer, Surgical Wounds, Trauma Wounds, Diabetic Ulcer.
What interventions are being tested in trial NCT03286452?
The interventions under investigation include: PuraPly™ Antimicrobial Wound Matrix (DEVICE).
Who is sponsoring clinical trial NCT03286452?
This trial is sponsored by Organogenesis, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03286452 being conducted?
This trial has 15 study locations across Arizona, Florida, Louisiana, Missouri, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Tissue Repair Gel in Venous Leg Ulcers in AU/US
RECRUITING · Phase 3
-
Evaluating the Durability of Closure for Venous Leg Ulcers
RECRUITING
-
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
RECRUITING · NA
-
A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers.
RECRUITING · Phase 4
-
Tissue Repair Gel in Venous Leg Ulcers (US)
RECRUITING · Phase 3
-
The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.